News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,923 Results
Type
Article (215)
Company Profile (1)
Press Release (1707)
Section
Business (676)
Career Advice (1)
Deals (122)
Drug Delivery (7)
Drug Development (101)
FDA (16)
Job Trends (27)
News (908)
Policy (98)
Tag
Academia (3)
Alliances (226)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (3)
Approvals (17)
Autoimmune disease (3)
Best Places to Work (12)
BIOSECURE Act (18)
Biotechnology (1)
Cancer (8)
Cardiovascular disease (1)
Career advice (1)
CAR-T (3)
Cell therapy (9)
Clinical research (82)
Collaboration (11)
COVID-19 (8)
C-suite (3)
Data (7)
Diagnostics (16)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (187)
Editorial (1)
Events (159)
Executive appointments (6)
FDA (19)
Funding (4)
Gene therapy (1)
GLP-1 (8)
Government (27)
Healthcare (26)
Immunology and inflammation (3)
Immuno-oncology (1)
Infectious disease (8)
Intellectual property (1)
IPO (63)
IRA (1)
Job creations (13)
Job search strategy (1)
Layoffs (3)
Legal (9)
Lung cancer (1)
Manufacturing (28)
MASH (1)
Medical device (18)
Medtech (18)
Mergers & acquisitions (64)
Metabolic disorders (4)
Multiple sclerosis (3)
NASH (1)
Neuroscience (5)
NextGen: Class of 2025 (18)
Non-profit (2)
Obesity (2)
Opinion (4)
People (167)
Phase I (53)
Phase II (34)
Phase III (12)
Pipeline (14)
Policy (23)
Preclinical (8)
Real estate (63)
Regulatory (69)
Reports (1)
Research institute (1)
Series B (1)
Startups (39)
Supply chain (4)
Tariffs (1)
The Weekly (4)
Vaccines (2)
Venture capital (1)
Weight loss (2)
Date
Last 7 days (4)
Last 30 days (11)
Last 365 days (96)
2025 (90)
2024 (127)
2023 (113)
2022 (218)
2021 (205)
2020 (159)
2019 (116)
2018 (132)
2017 (117)
2016 (97)
2015 (117)
2014 (76)
2013 (60)
2012 (43)
2011 (38)
2010 (48)
Location
Africa (2)
Asia (953)
Australia (13)
California (21)
Canada (2)
China (57)
Europe (141)
Florida (1)
Illinois (1)
India (2)
Japan (1)
Maryland (1)
Massachusetts (15)
New Jersey (18)
New York (1)
North Carolina (1)
Northern California (12)
Ohio (2)
Pennsylvania (3)
South America (1)
Southern California (5)
Texas (1)
United States (66)
Utah (1)
Washington D.C. (3)
1,923 Results for "wuxi nextcode".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry
November 20, 2025
·
5 min read
Press Releases
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year
October 10, 2025
·
3 min read
Press Releases
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
October 28, 2025
·
3 min read
Press Releases
WuXi Biologics Reports Solid 2025 Interim Results
August 20, 2025
·
16 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK)
September 17, 2025
·
3 min read
Press Releases
Driving Biopharma Commercial Success through Redefined CRDMO Partnerships
Dr. Chris Chen, CEO of WuXi Biologics, answers questions about recent developments, novel platforms, and how to stay ahead of rapid developments to ensure quality, reliability and speed of delivery
November 14, 2025
·
1 min read
BIOSECURE Act
WuXi Mulls Sale of Some US, European Operations: FT
The
Financial Times
reported Thursday that WuXi AppTec is looking to sell its cell and gene therapy manufacturing unit, with facilities in Philadelphia, while WuXi Biologics wants to offload some of its production sites in Europe.
October 3, 2024
·
2 min read
·
Tristan Manalac
Press Releases
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance
October 27, 2025
·
22 min read
Press Releases
WuXi AppTec Completes Second RMB1.0 Billion A-Share Repurchase Program in 2025, All Repurchased Shares to Be Cancelled
August 28, 2025
·
1 min read
1 of 193
Next
